This inventor holds 1 USPTO granted patent. Top assignee: Mylan Gmbh. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Vikram Bindra: Innovator in Transdermal Therapeutic Systems
Introduction
Vikram Bindra is a notable inventor based in Panipat, India. He has made significant contributions to the field of medical technology, particularly in the development of transdermal therapeutic systems. His innovative work focuses on improving the delivery of medications for neurological disorders.
Latest Patents
Vikram Bindra holds a patent for a transdermal therapeutic system designed for the extended dosing of pramipexole. This system is particularly beneficial in treating neurological disorders. The patent describes a transdermal therapeutic system (TTS) that contains pramipexole or related compounds. It outlines methods for creating the system and its application in administering a single dose over an extended period, such as one week. The system features an acrylic-based or silicone-based matrix layer that includes pramipexole at concentrations of at least about 5 wt. % of the matrix. This design is resistant to crystallization and discoloration of the active ingredient, even when stored for long durations.
Career Highlights
Vikram Bindra is currently associated with Mylan GmbH, a global healthcare company known for its commitment to providing high-quality medicines. His work at Mylan has allowed him to further his research and development efforts in the pharmaceutical industry.
Collaborations
Some of Vikram's coworkers include Abhijit Mukund Deshmukh and Akhilesh Dixit. Their collaboration has contributed to the advancement of innovative solutions in the field of pharmaceuticals.
Conclusion
Vikram Bindra's contributions to transdermal therapeutic systems exemplify the importance of innovation in healthcare. His work not only enhances medication delivery but also improves patient outcomes in treating neurological disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
